Zolacos may be available in the countries listed below.
Ingredient matches for Zolacos
Bicalutamide is reported as an ingredient of Zolacos in the following countries:
- Australia
International Drug Name Search
Zolacos may be available in the countries listed below.
Bicalutamide is reported as an ingredient of Zolacos in the following countries:
International Drug Name Search
Oftacilox may be available in the countries listed below.
Ciprofloxacin hydrochloride (a derivative of Ciprofloxacin) is reported as an ingredient of Oftacilox in the following countries:
International Drug Name Search
Doxycyclin-ratiopharm may be available in the countries listed below.
Doxycycline hyclate (a derivative of Doxycycline) is reported as an ingredient of Doxycyclin-ratiopharm in the following countries:
International Drug Name Search
Apo Clopidogrel may be available in the countries listed below.
Clopidogrel is reported as an ingredient of Apo Clopidogrel in the following countries:
Clopidogrel hydrogen sulfate (a derivative of Clopidogrel) is reported as an ingredient of Apo Clopidogrel in the following countries:
International Drug Name Search
Vertel may be available in the countries listed below.
Pyrantel embonate (a derivative of Pyrantel) is reported as an ingredient of Vertel in the following countries:
International Drug Name Search
Merrem is a brand name of meropenem, approved by the FDA in the following formulation(s):
Yes. The following products are equivalent to Merrem:
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Merrem. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
There are no current U.S. patents associated with Merrem.
Pentoxicux may be available in the countries listed below.
Pentoxifylline is reported as an ingredient of Pentoxicux in the following countries:
International Drug Name Search
Aceprom may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Acepromazine maleate (a derivative of Acepromazine) is reported as an ingredient of Aceprom in the following countries:
International Drug Name Search
In the US, Zolinza (vorinostat systemic) is a member of the drug class histone deacetylase inhibitors and is used to treat Cutaneous T-cell Lymphoma.
US matches:
Vorinostat is reported as an ingredient of Zolinza in the following countries:
International Drug Name Search
Zantic 75 may be available in the countries listed below.
Ranitidine hydrochloride (a derivative of Ranitidine) is reported as an ingredient of Zantic 75 in the following countries:
International Drug Name Search
Zovir may be available in the countries listed below.
Aciclovir is reported as an ingredient of Zovir in the following countries:
Aciclovir sodium salt (a derivative of Aciclovir) is reported as an ingredient of Zovir in the following countries:
International Drug Name Search
Acido clavulanico may be available in the countries listed below.
Acido clavulanico (DCIT) is known as Clavulanate in the US.
International Drug Name Search
Glossary
DCIT | Denominazione Comune Italiana |
Oxedrine Tartrate may be available in the countries listed below.
Oxedrine Tartrate (BANM) is also known as Oxedrine (BAN)
International Drug Name Search
Glossary
BAN | British Approved Name |
BANM | British Approved Name (Modified) |
Reducid may be available in the countries listed below.
Ranitidine is reported as an ingredient of Reducid in the following countries:
International Drug Name Search
bye-VAL-i-roo-din
In the U.S.
Available Dosage Forms:
Therapeutic Class: Anticoagulant
Pharmacologic Class: Thrombin Inhibitor, Direct
Chemical Class: Hirudin Related
Bivalirudin is used together with aspirin to decrease the clotting ability of the blood and to help prevent harmful clots from forming in the blood vessels. It is used in patients who are having certain heart and blood vessel procedures, such as coronary angioplasty.
bivalirudin is available only with your doctor's prescription.
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For bivalirudin, the following should be considered:
Tell your doctor if you have ever had any unusual or allergic reaction to bivalirudin or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Appropriate studies have not been performed on the relationship of age to the effects of bivalirudin in the pediatric population. Safety and efficacy have not been established.
Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of bivalirudin in the elderly. However, elderly patients are more likely to have bleeding problems than younger adults, which may require caution in patients receiving bivalirudin.
Pregnancy Category | Explanation | |
---|---|---|
All Trimesters | B | Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate studies in pregnant women OR animal studies have shown an adverse effect, but adequate studies in pregnant women have failed to demonstrate a risk to the fetus. |
There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are receiving bivalirudin, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.
Using bivalirudin with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
Using bivalirudin with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.
The presence of other medical problems may affect the use of bivalirudin. Make sure you tell your doctor if you have any other medical problems, especially:
A nurse or other trained health professional will give you bivalirudin. bivalirudin is given through a needle placed into one of your veins.
It is very important that your doctor check you at regular visits after you leave the hospital for any problems or unwanted effects that may be caused by bivalirudin. Be sure to keep all appointments.
Bivalirudin may increase your chance of bleeding. Check with your doctor right away if you notice any unusual bleeding or bruising; black, tarry stools; blood in the urine or stools; or pinpoint red spots on your skin. Avoid picking your nose. If you need to blow your nose, blow it gently.
Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor or nurse immediately if any of the following side effects occur:
Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
See also: bivalirudin Intravenous side effects (in more detail)
The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.
The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.